ArticleHeliyon2024
Fabrication of sustainable functional cotton fabric with silk sericin and chitosan for protective textiles.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fabrication and Properties of Chitosan/Calcium Polyphosphate Fibre Composite Biological Scaffold.Gels (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of bio-based sources for producing multifunctional cotton fabric with UV-protective and antibacterial properties is essential. Hence, the primary aim of this work was to develop sustainable functional cotton fabric (antibacterial and UV-protective) by applying silk sericin and chitosan using a simple and environmentally benign pad-dry curing method. The modification as well as functional properties of the treated fabric were evaluated in terms of antimicrobial efficacy, moisture management, UV protection, scavenging activity, surface morphology, thermal stability and mechanical strength. The results indicated that the concentration of chitosan around 10 mg/mL demonstrated remarkable antibacterial efficacy against gram-positive
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.